| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9030 |
| Human Intestinal Absorption | HIA+ | 0.9896 |
| Caco-2 Permeability | Caco2+ | 0.6297 |
| P-glycoprotein Substrate | Non-substrate | 0.5520 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5442 |
| Inhibitor | 0.5393 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8358 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6440 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8247 |
| CYP450 2D6 Substrate | Non-substrate | 0.9091 |
| CYP450 3A4 Substrate | Non-substrate | 0.5773 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9237 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7521 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9047 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.9101 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.7960 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7534 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9676 |
| Non-inhibitor | 0.9569 |
| AMES Toxicity | AMES toxic | 0.7091 |
| Carcinogens | Non-carcinogens | 0.9472 |
| Fish Toxicity | High FHMT | 0.9360 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9782 |
| Honey Bee Toxicity | High HBT | 0.8451 |
| Biodegradation | Not ready biodegradable | 0.7842 |
| Acute Oral Toxicity | III | 0.5132 |
| Carcinogenicity (Three-class) | Warning | 0.4385 |